Evidence map›Paper›PMID 40225134›Full record

ArticleMaterials today. Bio2025

Defect-engineered magnetic bismuth nanomedicine for dual-modal imaging and synergistic lung tumor therapy.

Pengpeng Jia, Jie Tu, Hongyu Shen, Yuqin Jiang, Qiupeng Zhang, Weixian Xue, Meitong Liu, Jianbo Liu, Yuqing Miao, Ruizhuo Ouyang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pengpeng JiaInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Jie TuInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Hongyu ShenInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Yuqin JiangCollaborative Innovation Centre of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Henan Engineering Research Centre of Chiral Hydroxyl Pharmaceutical, Henan Engineering Laboratory of Chemical Pharmaceutical and Biomedical Materials, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, 453007, China.
Qiupeng ZhangInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Weixian XueInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Meitong LiuInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Jianbo LiuState Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.
Yuqing MiaoInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Ruizhuo OuyangInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Shuang ZhouCancer Institute, Tongji University School of Medicine, Shanghai, 200092, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bismuth sulfide (Bi

Indexed as

Collaborative therapyDefect engineeringFe3O4@Au@Bi2S3Magnetic targetingNIRPTT

Identifiers

PMID40225134
PMCPMC11987673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.